InsidersTradesSigma
迈瑞医疗 Stock: price and management transactions · China · SSE / SZSE (CSRC)
Follow the 迈瑞医疗 share price and the full management transaction log of the company, a publicly traded company based in China. Shares trade on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 迈瑞医疗 has published 14 insider filings. Market capitalisation: €177.1bn. The latest transaction was filed on 3 June 2026 (Purchase). Among the most active insiders: LI XITING. Every trade is openly available.
14
Insider Decl.
0
Thresholds
·
14 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 迈瑞医疗 Strong Buy (bullish), based on 18 analysts. Average price target: CN¥237.88.
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 3,477 of 25,837 companies
71.0
score / 100
Value55
Quality87
FCF yld4.8%
Earn yld4.8%
EV/EBITDA14.8x
ROE19%
Gross mgn60%
Net mgn24%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 June 2026
Declarations14 total
14 of 14 declarations